ARCHIVES

Two-Year Remission While Taking Gleevec Puts Patients Into Normal Mortality Rate

This article is from The Cancer Letter archive.

Vol. 34 No. 3 | March 25, 2011

Download PDF Visit The Full Archive

Related Articles

NCI Advisors Approve Research Network On Screening

August 6, 2010

Coalition On Smoking Or Health to Launch Effort at $5 Tax Increase

July 3, 1992

ASCO To Begin Large Study On Quality Of Cancer Care.

January 28, 2000

DCE Advisors Approve New Grant Program On Lung Carcinoma

June 30, 1995

FDA, NCI Remain At Odds Over Drug approval Guidelines Despite Reconciliation Discussion

October 9, 1987

DCT Advisors OK 2 Grant Programs, Disapprove One, In NCI Effort To Improve Funding For Clinical Research

March 8, 1991